Myeloablative therapy against high risk Ewing's sarcoma: A single institution experience and literature review

about

Myeloablative therapy against high risk Ewing's sarcoma: A single institution experience and literature review

Item

http://www.wikidata.org/entity/Q37392265

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Myeloablative therapy against ...... perience and literature review

@en

Myeloablative therapy against ...... erience and literature review.

@nl

type

Item

label

Myeloablative therapy against ...... perience and literature review

@en

Myeloablative therapy against ...... erience and literature review.

@nl

prefLabel

Myeloablative therapy against ...... perience and literature review

@en

Myeloablative therapy against ...... erience and literature review.

@nl

P1476

Myeloablative therapy against ...... perience and literature review

@en

P2093

Concepcion Pérez

http://www.w3.org/2001/XMLSchema#string

Gema Lucia Ramirez

http://www.w3.org/2001/XMLSchema#string

Jose Luis Lopez

http://www.w3.org/2001/XMLSchema#string

Jose Maria Perez

http://www.w3.org/2001/XMLSchema#string

Maria Jose Ortiz

http://www.w3.org/2001/XMLSchema#string

Rafael Ordoñez

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data.

How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.

Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital.

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.

Molecular confirmation of Ewing sarcoma.

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

High-dose therapy with autologous stem cell rescue for pediatric sarcomas.

Autologous bone marrow transplantation in pediatric solid tumors: phase II studies.

Role of radiation therapy in the multidisciplinary management of Ewing's Sarcoma of bone in pediatric patients: An effective treatment for local control.

P304

163-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.RPOR.2011.04.002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Juan Manuel Praena-Fernandez

Catalina Márquez

P Cabrera Roldán

P577

2011-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

251680694

http://www.w3.org/2001/XMLSchema#string

P698

24376974

http://www.w3.org/2001/XMLSchema#string

P932

3863224

http://www.w3.org/2001/XMLSchema#string